These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2245495)

  • 1. Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.
    Hasle H
    Cancer Chemother Pharmacol; 1990; 27(1):76-8. PubMed ID: 2245495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytarabine-induced cerebellar syndrome: case report and literature review.
    Sylvester RK; Fisher AJ; Lobell M
    Drug Intell Clin Pharm; 1987 Feb; 21(2):177-80. PubMed ID: 3470173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellar toxicity following high-dose cytosine arabinoside.
    Dworkin LA; Goldman RD; Zivin LS; Fuchs PC
    J Clin Oncol; 1985 May; 3(5):613-6. PubMed ID: 3998779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine.
    Jolson HM; Bosco L; Bufton MG; Gerstman BB; Rinsler SS; Williams E; Flynn B; Simmons WD; Stadel BV; Faich GA
    J Natl Cancer Inst; 1992 Apr; 84(7):500-5. PubMed ID: 1545440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar dysfunction during high dose cytosine arabinoside therapy in a case of acute myelogenous leukaemia.
    Cold S
    Scand J Haematol; 1986 Feb; 36(2):165-7. PubMed ID: 3458292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cerebellar toxicity after high-dose cytarabine associated with CNS accumulation of its metabolite, uracil arabinoside.
    Lopez JA; Agarwal RP
    Cancer Treat Rep; 1984 Oct; 68(10):1309-10. PubMed ID: 6098367
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency.
    Chim CS; Kwong YL
    Am J Hematol; 1996 Nov; 53(3):208. PubMed ID: 8895701
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebellar toxicity due to cytarabine: A series of 4 cases.
    Sainz de la Maza Cantero S; Jiménez Martín A; de Felipe Mimbrera A; Corral Corral Í
    Neurologia; 2016 Sep; 31(7):491-2. PubMed ID: 25728956
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebellar toxicity with high-dose cytosine arabinoside.
    Herzig RH; Hines JD; Herzig GP; Wolff SN; Cassileth PA; Lazarus HM; Adelstein DJ; Brown RA; Coccia PF; Strandjord S
    J Clin Oncol; 1987 Jun; 5(6):927-32. PubMed ID: 3585447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe persistent cerebellar dysfunction complicating cytosine arabinoside therapy.
    Boesen P; Fallingborg J; Spaun E
    Acta Med Scand; 1988; 224(2):189-91. PubMed ID: 3166602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system toxicity of high-dose systemic cytosine arabinoside.
    Lazarus HM; Herzig RH; Herzig GP; Phillips GL; Roessmann U; Fishman DJ
    Cancer; 1981 Dec; 48(12):2577-82. PubMed ID: 7306918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between high-dose cytarabine neurotoxicity and renal insufficiency.
    Damon LE; Mass R; Linker CA
    J Clin Oncol; 1989 Oct; 7(10):1563-8. PubMed ID: 2778484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.
    Thordarson H; Talstad I
    Acta Med Scand; 1986; 220(5):493-5. PubMed ID: 3468760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retreatment with low-dose cytarabine in patients with previous central nervous system toxicity.
    Olavarria E; Prieto E; Roman A
    Am J Hematol; 1997 Apr; 54(4):338. PubMed ID: 9092694
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute cerebellar syndrome, conjunctivitis, and hearing loss associated with low-dose cytarabine administration.
    Cersosimo RJ; Carter RT; Matthews SJ; Coderre M; Karp DD
    Drug Intell Clin Pharm; 1987 Oct; 21(10):798-803. PubMed ID: 3428138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cerebellar dysfunction with high-dose Ara-C therapy.
    Lazarus HM
    Cancer; 1984 Jun; 53(12):17A. PubMed ID: 6722718
    [No Abstract]   [Full Text] [Related]  

  • 17. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
    Pellier I; Leboucher B; Rachieru P; Ifrah N; Rialland X
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):837-9. PubMed ID: 17164656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytarabine and neurologic toxicity.
    Baker WJ; Royer GL; Weiss RB
    J Clin Oncol; 1991 Apr; 9(4):679-93. PubMed ID: 1648599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.
    Smith GA; Damon LE; Rugo HS; Ries CA; Linker CA
    J Clin Oncol; 1997 Feb; 15(2):833-9. PubMed ID: 9053511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system effects of high-dose cytosine arabinoside.
    Herzig RH; Herzig GP; Wolff SN; Hines JD; Fay JW; Phillips GL
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):21-4. PubMed ID: 3589694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.